5 July 2023
Announcements, EMBL Announcements
Coming from a pharmaceutical industry background, David Hulcoop is set to take over as Executive Director of the public-private partnership Open Targets.
2023
announcementsembl-announcements
27 February 2023
Research highlights, Science
Researchers create a network of interacting proteins – or interactome – to aid drug discovery.
2023
research-highlightsscience
26 January 2023
Science, Science & Technology, Technology and innovation
Open Targets is using artificial intelligence and machine learning to identify and prioritise drug targets.
2023
sciencescience-technologytechnology-and-innovation
11 November 2022
Announcements, Science
Open Targets announces that Genentech will become the seventh partner in the drug discovery and validation consortium.
2022
announcementsscience
10 February 2022
Announcements, Connections, Science
Open Targets, a consortium focused on drug target identification, prioritisation, and validation, announced today that Pfizer has joined as a partner.
2022
announcementsconnectionsscience
19 October 2021
Lab Matters, People & Perspectives
Ian Dunham walks us through his career so far including working on the human genome project, seeing his work on the cover of Nature and his current role as Director of Open Targets.
2021
lab-matterspeople-perspectives
21 July 2021
Science, Science & Technology
Researchers establish a framework for identifying new drugs capable of exploiting a cell’s own machinery.
2021
sciencescience-technology
No matching posts found